908 related articles for article (PubMed ID: 33201261)
1. [Evidence-based treatment of cystic fibrosis].
Ringshausen FC; Hellmuth T; Dittrich AM
Internist (Berl); 2020 Dec; 61(12):1212-1229. PubMed ID: 33201261
[TBL] [Abstract][Full Text] [Related]
2. Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.
Harutyunyan M; Huang Y; Mun KS; Yang F; Arora K; Naren AP
Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L529-L543. PubMed ID: 29351449
[TBL] [Abstract][Full Text] [Related]
3. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
Kuk K; Taylor-Cousar JL
Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827
[TBL] [Abstract][Full Text] [Related]
4. [Cystic fibrosis in childhood and adulthood].
Syunyaeva Z; Mall MA; Stahl M
Inn Med (Heidelb); 2024 Jun; 65(6):538-544. PubMed ID: 38714556
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis.
Fajac I; Burgel PR
Presse Med; 2023 Sep; 52(3):104169. PubMed ID: 37516246
[TBL] [Abstract][Full Text] [Related]
6. [Patients with cystic fibrosis become adults : Treatment hopes and disappointments].
Eschenhagen P; Schwarz C
Internist (Berl); 2019 Jan; 60(1):98-108. PubMed ID: 30627755
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function.
Arora K; Naren AP
Curr Drug Targets; 2016; 17(11):1275-81. PubMed ID: 26648081
[TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis.
Burgener EB; Moss RB
Curr Opin Pediatr; 2018 Jun; 30(3):372-377. PubMed ID: 29538046
[TBL] [Abstract][Full Text] [Related]
9. Advances in the diagnosis and treatment of cystic fibrosis.
Martiniano SL; Hoppe JE; Sagel SD; Zemanick ET
Adv Pediatr; 2014 Aug; 61(1):225-43. PubMed ID: 25037130
[TBL] [Abstract][Full Text] [Related]
10. A foetus with cystic fibrosis - To treat or not to treat?
Padmakumar N; Khan HS
Respir Med Res; 2023 Jun; 83():101006. PubMed ID: 37037055
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of cystic fibrosis treatment.
Carter SC; McKone EF
Pharmacogenomics; 2016 Aug; 17(13):1453-63. PubMed ID: 27490265
[TBL] [Abstract][Full Text] [Related]
12. What's new in cystic fibrosis? From treating symptoms to correction of the basic defect.
Proesmans M; Vermeulen F; De Boeck K
Eur J Pediatr; 2008 Aug; 167(8):839-49. PubMed ID: 18389279
[TBL] [Abstract][Full Text] [Related]
13. CFTR: cystic fibrosis and beyond.
Mall MA; Hartl D
Eur Respir J; 2014 Oct; 44(4):1042-54. PubMed ID: 24925916
[TBL] [Abstract][Full Text] [Related]
14. CFTR, mucins, and mucus obstruction in cystic fibrosis.
Kreda SM; Davis CW; Rose MC
Cold Spring Harb Perspect Med; 2012 Sep; 2(9):a009589. PubMed ID: 22951447
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis: a clinical view.
Castellani C; Assael BM
Cell Mol Life Sci; 2017 Jan; 74(1):129-140. PubMed ID: 27709245
[TBL] [Abstract][Full Text] [Related]
16. Nutritional management of people living with cystic fibrosis throughout life and disease continuum: Changing times, new challenges.
Mailhot G; Denis MH; Beauchamp-Parent C; Jomphe V
J Hum Nutr Diet; 2023 Oct; 36(5):1675-1691. PubMed ID: 37515397
[TBL] [Abstract][Full Text] [Related]
17. [Cystic fibrosis: molecular update and clinical implications].
Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
[TBL] [Abstract][Full Text] [Related]
18. Functional Consequences of CFTR Interactions in Cystic Fibrosis.
Ramananda Y; Naren AP; Arora K
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542363
[TBL] [Abstract][Full Text] [Related]
19. The Changing Face of Cystic Fibrosis: An Update for Anesthesiologists.
Lee AJ; Huffmyer JL; Thiele EL; Zeitlin PL; Chatterjee D
Anesth Analg; 2022 Jun; 134(6):1245-1259. PubMed ID: 35020677
[TBL] [Abstract][Full Text] [Related]
20. Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients.
Amaral MD
J Intern Med; 2015 Feb; 277(2):155-166. PubMed ID: 25266997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
